Publication · 2015
PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance
Oncogene
Corresponding authorPubMed
Citation
Fu Q. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance. Oncogene. 2015. Corresponding author.
- Year
- 2015
- Journal
- Oncogene
- Contribution
- Corresponding author
Source
View on PubMedhttps://pubmed.ncbi.nlm.nih.gov/25772246/Part of the research record of Professor Daniel Qiang Fu 付强.
More publications
2025
mRNA vaccines in the context of cancer treatment
Journal of Translational Medicine
2024
Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications
Review
2024
hUMSCs restore ovarian function in POI mice via GSK3β-mediated mitochondrial dynamics
Peer-reviewed article
2023
Rutin is a potent senomorphic agent
Aging Cell